-
Pharmaceutical Intermedia |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-N-Me-Trp(Boc)-OH |CAS No.:197632-75-0
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-N-Me-Trp(Boc)-OH |CAS:197632-75-0 |C32H32N2O6
-
Pharmaceutical Intermedia |Immunology |Peptide synthesis |Fmoc-Trp-OH |CAS No.:35737-15-6 |C26H22N2O4
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-Trp-OH |CAS:35737-15-6 |C26H22N2O4
-
Pharmaceutical Intermedia |Immunology |Peptide synthesis |Fmoc-His(Trt)-OH |CAS No.:109425-51-6 |C40H33N3O4
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-His(Trt)-OH |CAS:109425-51-6 |C40H33N3O4
-
Pharmaceutical Intermedia |Immunology |Peptide synthesis |Fmoc-Lys(Boc)-OH |CAS No.:71989-26-9
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-Lys(Boc)-OH |CAS:71989-26-9 |C26H32N2O6
-
Fmoc-D-Trp(Boc)-OH 163619-04-3
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Natural Amino Acid |Fmoc-D-Trp(Boc)-OH |CAS:163619-04-3 |C31H30N2O6
-
Pharmaceutical Intermedia |Morbi respiratorii |Pranlukast Intermedia |3′-Acetylamino-2′-hydroxyacetophenone |CAS No.103205-33-0
Lorem vestibulum ac copia biopharmaceutical |Pharmaceutical Intermedia Reagents |Rudis materiae |Morbi respiratorii |Pranlukast Intermedia |3′-Acetylamino-2′-hydroxyacetophenone |CAS:103205-33-0 |C10H11NO3
-
Pharmaceutical Intermedia |Dabigatran Intermedia |N-(4-CYANO-PHENYL)-GLYCINE |CAS No.42288-26-6
Lorem vestibulum ac copia biopharmaceutical |Pharmaceutical Intermedia Reagents |Rudis materiae |Anticoagulant API |Dabigatran Intermedia |N-(4-CYANO-PHENYL)-GLYCINE |CAS:42288-26-6 |C9H8N2O2
-
Pharmaceutical Intermedia |Integrin hosti |Lifitegrast Intermedia |3-Bromo-L-phenylalanine |CAS No
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia |Lifitegrast Intermedia |3-Bromo-L-phenylalanine |CAS:82311-69-1 |C9H10BrNO2
-
Pharmaceutical Intermedia |Integrin hosti |Lifitegrast Intermedia |Boc-3-bromo-L-phenylalanine |CAS No
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia |Integrin hosti |Lifitegrast Intermedia |Boc-3-bromo-L-phenylalanine |CAS:82278-73-7 |C14H18BrNO4
-
Pharmaceutical Raw Material and Intermedia |Diabetes |(R) -3-Aminopiperidine dihydrochloride |CAS No
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Active Pharmaceutical Ingredient Intermedia |Diabetes |(R) -3-Aminopiperidine dihydrochloride |CAS:334618-23-4 |C5H14Cl2N2
-
Pharmaceutical Intermedia |(R) -1-Boc-3-Aminopiperidine |Diabetes |CAS:188111-79-7
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Pharmaceutical Intermedia |(R) -1-Boc-3-Aminopiperidine |CAS:188111-79-7 |C10H20N2O2
-
Raw Materials |Pharmaceutical Intermedia |Cardiovascular |Diseases |(S)-(-)-Indoline-2-acidi carboxylicum |CAS No
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Cardiovascular Diseases |High Blood Pressure |(S)-(-)-Indoline-2-acidi carboxylicum |CAS:79815-20-6 |C9H9NO2